期刊文献+

生孢梭菌作为肿瘤基因治疗载体应用方式与动态分布 被引量:1

THE WAY OF APPLICATION AND DYNAMIC DISTRIBUTION OF CLOSTRIDIUM SPOROGENES AS VECTOR FOR TUMOR GENE THERAPY
下载PDF
导出
摘要 目的探讨生孢梭菌在乳癌小鼠体内的应用方式与动态分布,为实体瘤治疗中生孢梭菌的具体应用提供参考。方法制备小鼠乳癌模型。取生孢梭菌的芽胞和繁殖体,以尾静脉和瘤内注射两种方式注射到乳癌小鼠体内,定期随机选取小鼠,处死后取其肝、肾、脾等重要器官以及肿瘤组织制作印片,经革兰染色后镜下观察。同时取组织匀浆进行厌氧培养,观察不同时期组织内细菌分布情况。结果生孢梭菌的繁殖体与芽胞一样可以在低氧的乳癌内部定居繁殖,且没有观察到明显的毒性。静脉注射后,生孢梭菌可以在肿瘤内大量繁殖,与瘤内注射的结果相同;与瘤内注射不同的是,各器官中有少量细菌分布,但随时间的推移很快被清除。生孢梭菌在肿瘤消退之前被进入肿瘤内部的中性粒细胞吞噬消除。结论生孢梭菌是一种靶向性好、安全性高、自限性的实体瘤治疗的靶向载体;在实体瘤的靶向治疗中,可以采用静脉注射的方式,随意采用生孢梭菌的繁殖体、芽胞或二者混合物作为载体将抗肿瘤基因定向送至肿瘤内部发挥作用。 Objective To investigate the application and dynamic distriEution of Clostridiurn sporogenes in breast-eaneer- bearing mice and provide a reference of specific use of Clostridium sporogenes in the treatment of solid tumors. Methods A breast catlcer model was created in mice. Endospofes and vegetative forms of Clostridium sporogenes were injected into the models through caudal vein and tumor. The mice were selected regularly and killed, the livers, kidneys, spleens and tumors were taken for slice, gram's stain, and observed microscopically. The homogenate of these tissues were collected for anaerobic culture. The bacte- rial distribution in tissue of different time was observed. Results Vegetative forms of Clostridium sporogenes-like endospores- could survive and breed inside the mionectic environment of breast cancer, with no apparent toxicity. Clostridium sporogenes could massively multiply after intravenous injection, the result was the same as iniccting into the tumor, the different from irttratumor injection was that a few bacteria could be seen in some organs, they would be cleared soon as the time lapsed. The C1ostridium sporogenes were phagocytized by neutrophils that entered the tumor before tumor regression. Conclusion Clostridium sporo- genes is a well targeting, high safety and self-limited vector in solid tumor targeted therapy. In the targeted therapy, intravenous injection of either vegetative forms or spores, or both of them, can be applied at will as a vector to play a role inside the tumor.
出处 《青岛大学医学院学报》 CAS 2013年第6期476-478,481,共4页 Acta Academiae Medicinae Qingdao Universitatis
基金 山东省自然科学基金项目(ZR2012HQ005) 山东省医药卫生科技发展计划项目(2009HD005) 青岛大学2011年创新型教学实验室研究项目 青岛大学医学院2012年度本科生基础医学创新实验项目
关键词 生孢梭菌 繁殖体 芽胞 乳腺肿瘤 尾静脉注射 瘤内注射 clostridium sporogenes vegetative forms spores breast cancer caudal vein injection intratumoral injec-tion
  • 相关文献

参考文献8

  • 1DANG L H, BETTEGOWDA C,HUSO D L, et al. Combination bacteriolytic therapy for the treatment of experimental tumors E J. Proc Natl Aead Sci USA, 2001,98(26) :15155-15160.
  • 2WEI M Q, ELLEM K A, DUNN P, et al. Facultative or ob- ligate anaerobic bacteria have the potential for multimodality therapy of solid tumours[J]. Eur J Cancer, 2007,43 (3) : 490 496.
  • 3LIU S C, MINTON N P, GIACCIA A J, et al. Anticancer ef- ficacy of systemically delivered anaerobic bacteria as gene the- rapy vectors targeting tumor hypoxia/necrosis[J]. Gene Ther, 2002,9 (4) 291-296.
  • 4THEYS J, PENNINGTON O, DUBOIS L, et al. Repeated cycles of clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo[J]. Br J Cancer, 2006,95(9)1212-1219.
  • 5LIU S C, AHN G O, KIOI M, et al. Optimized clostridia-di- rected enzyme prodrug therapy improves the antitumor activity of the novel DNA-cross-linking agent PR-104[J]. Cancer Res, 2008,68(19) :7995-8003.
  • 6张艳丽,张文卿,王秋波,丁守怡,吕锐,董海.hIL-12及HER2/neu ECD修饰的生孢梭菌工程菌的构建及鉴定[J].免疫学杂志,2011,27(11):987-991. 被引量:2
  • 7黄立惠,张文卿,于红,张艳丽,王明翠.诺氏梭菌作为基因载体的靶向性与安全性[J].青岛大学医学院学报,2012,48(4):327-329. 被引量:1
  • 8张清华,王言奎.宫颈癌组织HIF-1α和IGF-2表达及意义[J].齐鲁医学杂志,2011,26(1):8-10. 被引量:7

二级参考文献35

  • 1徐军,施红旗,刘庆伟,楼善贤.HIF-1α、VEGF在宫颈鳞癌中的表达及临床意义[J].浙江实用医学,2006,11(1):6-8. 被引量:4
  • 2VAN DIEST PJ,VLEUGEL M M,VAN DER WALL E.Expression of HIF-1 alpha in human tumours[J].J Clin Pathol,2005,58(3):335-336.
  • 3FUJIMOTO J,ALAMS M,JAHAN I.Plausible linkage of hypoxia inducible factor-lalpha in uterine cervical cancer[J].CancerSci,2006,97(9):861-867.
  • 4KORNPRAT P,REHAK P,RUSCHOFF J,et al.Expression of IGF-1,IGF-2,and IGF-1R in gallbladder carcinoma.A systematic analysis including primary and corresponding metastatic tumours[J].J Clin Pathol,2006,59(2):202-206.
  • 5LU L,KATSAROS D,WILEY A,et al.The relationship of insulin-like growth factor-Ⅱ,insulin-like growth factor binding protein-3,and estrogen recepto r-alpha expression to disease progression in epithelial ovarian cancer[J].Clin Caner Res,2006,12(4) ;1208-1214.
  • 6YOON D,PASTORE Y D,DIVOKY V.HIF-lα deficiency results indysregulated EPO signaling and iron homeostasis in mouse development[J].J Biol Chem,2006,281 (35):2570325711.
  • 7Dimitriadis A, Gontinou C, Baxevanis CN, et al. The mannosylated extracellular domain of her2/neu produced in P.pastoris induces protective antitumor immunity [J]. BMC Cancer, 2009, 9: 386.
  • 8Wei MQ, Ellem OA, Dunn P, et al. Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours [J]. Eur J Cancer, 2007, 43 (3): 490-496.
  • 9Vaupel P, Kelleher DK, H~ckel M. Oxygen status of malignant tumors:pathogenesis of hypoxia and significance for tumor therapy[J~ Semin Oncol, 2001, 28(2 Suppl 8): 29-35.
  • 10Lambin P, Theys J, Landuyt W, et al. Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours[J]. Anaerobe, 1998, 4(4): 183-188.

共引文献7

同被引文献19

  • 1张文卿,王丽娜,刘志军,Dernard Mariameb,于红,杨忠思,于修平.用细胞因子流式细胞计数术体外检测重组人IL-12的生物学活性[J].中华微生物学和免疫学杂志,2006,26(4):383-384. 被引量:9
  • 2Zu C, Wang J. Tumor-colonizing bacteria: a potential tumor targeting therapy[J]. Crit Rev Microbial, 2014, 40(3): 225-35.
  • 3Carey RW, Holland JF, Whang HY, et al. Clostridial oncolysis in man[J]. Europ J Cancer, 1967, 3: 37-46.
  • 4Heppner F, Mose J, Ascher PW, et al. Oncolysis of malignant gliomas of the brain[J]. 13th Int Cong Chemother , 1983, 226: 38-45.
  • 5Liu SC, Ahn GO, Kioi M, et al. Optimized Clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104[J]. Cancer Res, 2008, 68 (9): 7995- 8003.
  • 6Liu SC, Minton NP, Giaccia AJ, et al. Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis] j]. Gene Ther, 2002, 9 (4): 291 -6.
  • 7Zaharoff DA, Hance KW, Rogers C], et al. Intratumoral immunotherapy of established solid tumors with chitosan/IL-12 [J]. I Immunother, 2010, 33(7): 697-705.
  • 8Sorensen EW. Gerber SA. Frelinger]G. et al. IL-12 suppresses vascular endothelial growth factor receptor 3 expression on tumor vessels by two distinct IFN-gamma-dependent mechanisms[J].] Immunol , 2010. 184(4): 1858-66.
  • 9Leonard]P. Sherman ML. Fisher GL. et al. Effects of singledose interleukin-LZ exposure on inrerleukin-Lz-associared toxicity and interferon-gamma production [J]. Blood. 1997. 90(7): 2541 -8.
  • 10Car BD. Eng VM. Lipman]M. et al. The toxicology of inter leukin-J Z, a review[J]. Toxicol Pathol , 1999. 27(1), 58-63.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部